Form 8-K - Current report:
SEC Accession No. 0001640334-21-003192
Filing Date
2021-12-16
Accepted
2021-12-16 06:02:57
Documents
16
Period of Report
2021-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bdpt_8k.htm   iXBRL 8-K 17877
2 EX-99.1 bdpt_ex991.htm EX-99.1 9247
8 bdpt_8kimg1.jpg GRAPHIC 8829
  Complete submission text file 0001640334-21-003192.txt   168736

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20211215.xsd EX-101.SCH 5631
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20211215_lab.xml EX-101.LAB 13289
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20211215_cal.xml EX-101.CAL 914
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20211215_pre.xml EX-101.PRE 8391
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20211215_def.xml EX-101.DEF 2121
9 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_8k_htm.xml XML 3283
Mailing Address 1015 S CIMARRON RD LAS VEGAS NV 89145
Business Address 1015 S CIMARRON RD LAS VEGAS NV 89145 (702) 560-1632
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54949 | Film No.: 211495905
SIC: 2834 Pharmaceutical Preparations